s6y
Company name or ticker
Search
Orexigen Therapeutics, Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Wednesday, October 24, 2012
Accession number
0001193125-12-433285
Documents
PROSPECTUS SUPPLEMENT
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header